Vantive Accelerates U.S. Home Therapy Transformation With New Digital and Patient Support InnovationsDEERFIELD, Ill., March 23, 2026 (GLOBE NEWSWIRE) -- Vantive, a vital organ therapy company with a 70-year legacy of kidney care innovation, today announced a significant expansion of its U.S. home therapy innovation strategy—including fully-integrated digital capabilities, enhanced patient support programs, and service model improvements designed to reshape how patients experience peritoneal dialysis (PD) at home.
Vantive Introduces HomeAdvantage: Digitally-Enabled Home Therapy Ecosystem Designed to Make Home Dialysis Easier to Start, Manage and SustainHomeAdvantage is powered by Vantive CONNECT, a suite of digital solutions supporting remote patient monitoring, patient engagement, and data-driven decision-making throughout home dialysis
Vantive and Innovative Renal Care Enter into a Long-Term Agreement Focused on Enhanced Use of Technology to Expand Home Dialysis TherapiesCollaboration Aims to Expand Peritoneal Dialysis (PD) Access, Enable Greater Connection Between Patients and Care Teams, and Optimize Home Dialysis Care Delivery
Vantive to Invest More Than $1 Billion in Advancing Kidney Care and Vital Organ Support Through Digitally-Enabled TherapiesFive-year global investment to fuel R&D and manufacturing expansion, supporting development of new technologies and services designed to improve therapy access, care experience and outcomes for patients
Baxter Kidney Care is Now Vantive, A New Standalone Vital Organ Therapy CompanyVantive builds on a 70-year legacy of kidney care leadership and innovation, with a singular focus on empowering patients and care teams with more flexible, collaborative and accessible care options
